BioClinica Names Mukhtar Ahmed as eClinical President
-Technology and Industry Leader to Head eClinical Business Unit-
NEWTOWN, Pa., April 20, 2015 /PRNewswire/ -- BioClinica®, Inc., a specialty clinical trials services and technology provider, today announced that Mukhtar Ahmed, a recognized business leader within the life sciences, healthcare and technology sectors, will join BioClinica on April 20th as President of its Global eClinical Business Unit.
Mr. Ahmed most recently served as Global Vice President at Oracle Corporation responsible for growing Global Consulting Services and leading the Life Sciences business toward transformative cloud platforms, big data solutions and digital medicine. During a career spanning more than 25 years in the healthcare research industry, Mr. Ahmed has held senior executive positions with multinational Contract Research Organizations and clinical informatics companies including Kendle, Parexel and Medidata.
"Mukhtar has an exemplary track record delivering significant business benefits and operational growth strategies within the clinical technology sector," BioClinica CEO John Hubbard said. "He has a deep understanding of our business and eClinical customers, making him the right leader to drive new levels of innovation and value in clinical development."
"BioClinica is an industry leader with a comprehensive product platform and technology-enabled services, and I look forward to expanding on this success," Ahmed said. "I'm honored and excited to take on a new role with an organization that has built a reputation for innovation and customer focus."
Mr. Ahmed is an industry advisor to a number of start-ups and mid-range private equity companies and is currently a board advisor for a European laboratory company. He has previously held board-level, non-executive posts with National Health Service primary care and strategic health trusts in the United Kingdom.
Mr. Ahmed is routinely an industry speaker on topics including scientific innovation, strategic outsourcing, business change management, and medical device and clinical technologies. He earned degrees including a B.S. in Applied Systems and an M.S. in Neurological Imaging from Brunel University, as well as an MBA and post graduate diploma in Computer Science from Buckinghamshire University College.
BioClinica will host its annual Trial Blazers Customer Conference in the Orlando, Florida area on May 5 and 6. Follow BioClinica on the Trial Blazers blog at http://www.bioclinica.com/blog, and on Twitter at http://twitter.com/bioclinica.
About BioClinica, Inc.
BioClinica is a specialty clinical trials services provider that improves the development of new medical therapies by delivering expertise and technologies that enhance clinical research data and analytics, worldwide. The company offers industry-leading medical imaging services, enterprise eClinical technologies, clinical research centers and cardiovascular safety solutions that bring quality and efficiency to every phase of clinical development. BioClinica's experience spans three decades and includes thousands of studies in all therapeutic areas. The company serves more than 400 pharmaceutical, biotechnology, and device organizations -- including all of the top 20 -- through a network of offices in the U.S., Europe and Asia. For more information, please visit www.bioclinica.com.
Logo - http://photos.prnewswire.com/prnh/20130403/PH87647LOGO
SOURCE BioClinica, Inc.
Share this article